Md Saiful Islam1,2, Most Zannatul Ferdous1, Ummay Soumayia Islam1, Abu Syed Md Mosaddek3,4, Marc N Potenza5,6,7,8, Shahina Pardhan9. 1. Department of Public Health and Informatics, Jahangirnagar University, Savar, Dhaka 1342, Bangladesh. 2. Youth Research Association, Savar, Dhaka 1342, Bangladesh. 3. Department of Pharmacology, Uttara Adhunik Medical College, Uttara, Dhaka 1230, Bangladesh. 4. Quest Bangladesh Biomedical Research Center, Lalmatia, Dhaka 1207, Bangladesh. 5. Department of Psychiatry, and Child Study Center, Yale School of Medicine, New Haven, CT 06510, USA. 6. Connecticut Mental Health Center, New Haven, CT 06519, USA. 7. Connecticut Council on Problem Gambling, Wethersfield, CT 06519, USA. 8. Department of Neuroscience, Yale University, New Haven, CT 06510, USA. 9. Vision and Eye Research Institute, School of Medicine, Anglia Ruskin University, Young Street, Cambridge CB1 2LZ, UK.
Abstract
Background: Coronavirus disease (COVID-19) has affected people's lives globally. While important research has been conducted, much remains to be known. In Bangladesh, initial treatment (self-administered, hospitalized), persistent COVID-19 symptoms ("long COVID-19"), and whether COVID-19 leads to changes in mental state, such as depressive symptoms, of people are not known. This study aimed to examine treatment, persistent symptoms, and depression in people who had been infected with COVID-19 in Bangladesh. Methods: A cross-sectional survey was conducted on 1002 individuals infected with COVID-19 (60% male; mean age = 34.7 ± 13.9; age range = 18-81 years), with data taken over a one-month period (11 September 2020 to 13 October 2020). A self-reported online questionnaire was used to collect data on socio-demographics, lifestyle, COVID-19 symptoms (during and beyond COVID-19), medication (over-the-counter or doctor-prescribed), and depression (assessed using the Patient Health Questionnaire (PHQ-9)). Results: Twenty-four percent of participants self-medicated with over-the-counter medicine when they were first diagnosed with COVID-19. Self-medication was higher among female vs. male respondents (29.6% vs. 20.2%, respectively, p = 0.002). A minority (20%) reported that they experienced persistent COVID-like symptoms after recovering from COVID-19. The most reported persistent symptoms were diarrhea (12.7%) and fatigue (11.5%). Forty-eight percent of participants were categorized as having moderate to severe depression. Based on multivariate regression analysis, depression during COVID-19 was positively associated with lower family income, poor health status, sleep disturbance, lack of physical activity, hypertension, asthma/respiratory problems, fear of COVID-19 re-infection, and persistent COVID-19 symptoms. Conclusions: The findings suggest a need for appropriate interventions for COVID-19 patients to promote physical and mental wellbeing.
Background: Coronavirus disease (COVID-19) has affected people's lives globally. While important research has been conducted, much remains to be known. In Bangladesh, initial treatment (self-administered, hospitalized), persistent COVID-19 symptoms ("long COVID-19"), and whether COVID-19 leads to changes in mental state, such as depressive symptoms, of people are not known. This study aimed to examine treatment, persistent symptoms, and depression in people who had been infected with COVID-19 in Bangladesh. Methods: A cross-sectional survey was conducted on 1002 individuals infected with COVID-19 (60% male; mean age = 34.7 ± 13.9; age range = 18-81 years), with data taken over a one-month period (11 September 2020 to 13 October 2020). A self-reported online questionnaire was used to collect data on socio-demographics, lifestyle, COVID-19 symptoms (during and beyond COVID-19), medication (over-the-counter or doctor-prescribed), and depression (assessed using the Patient Health Questionnaire (PHQ-9)). Results: Twenty-four percent of participants self-medicated with over-the-counter medicine when they were first diagnosed with COVID-19. Self-medication was higher among female vs. male respondents (29.6% vs. 20.2%, respectively, p = 0.002). A minority (20%) reported that they experienced persistent COVID-like symptoms after recovering from COVID-19. The most reported persistent symptoms were diarrhea (12.7%) and fatigue (11.5%). Forty-eight percent of participants were categorized as having moderate to severe depression. Based on multivariate regression analysis, depression during COVID-19 was positively associated with lower family income, poor health status, sleep disturbance, lack of physical activity, hypertension, asthma/respiratory problems, fear of COVID-19 re-infection, and persistent COVID-19 symptoms. Conclusions: The findings suggest a need for appropriate interventions for COVID-19patients to promote physical and mental wellbeing.
Authors: Max Hirshkowitz; Kaitlyn Whiton; Steven M Albert; Cathy Alessi; Oliviero Bruni; Lydia DonCarlos; Nancy Hazen; John Herman; Paula J Adams Hillard; Eliot S Katz; Leila Kheirandish-Gozal; David N Neubauer; Anne E O'Donnell; Maurice Ohayon; John Peever; Robert Rawding; Ramesh C Sachdeva; Belinda Setters; Michael V Vitiello; J Catesby Ware Journal: Sleep Health Date: 2015-10-31
Authors: Marta Makowska; Rafał Boguszewki; Michał Nowakowski; Monika Podkowińska Journal: Int J Environ Res Public Health Date: 2020-11-11 Impact factor: 3.390
Authors: Alize J Ferrari; Fiona J Charlson; Rosana E Norman; Scott B Patten; Greg Freedman; Christopher J L Murray; Theo Vos; Harvey A Whiteford Journal: PLoS Med Date: 2013-11-05 Impact factor: 11.069
Authors: Ivan Wing Chit Mak; Chung Ming Chu; Pey Chyou Pan; Michael Gar Chung Yiu; Veronica Lee Chan Journal: Gen Hosp Psychiatry Date: 2009-04-15 Impact factor: 3.238